CVRx, Inc. (CVRX)
3.00
-0.07
(-2.28%)
USD |
NASDAQ |
Sep 03, 16:00
3.00
0.00 (0.00%)
After-Hours: 17:37
CVRx Research and Development Expense (Annual) : 11.13M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 11.13M |
| December 31, 2024 | 11.13M |
| December 31, 2023 | 11.63M |
| December 31, 2022 | 9.952M |
| Date | Value |
|---|---|
| December 31, 2021 | 7.501M |
| December 31, 2020 | 6.41M |
| December 31, 2019 | 8.662M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| NeuroPace, Inc. | 27.89M |
| Accuray, Inc. | 37.75M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 65.85M |
| ResMed, Inc. | 378.28M |